IJR | XJR | IJR / XJR | |
Gain YTD | -1.961 | -1.609 | 122% |
Net Assets | 85.4B | 101M | 84,554% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 19.00 | 23.00 | 83% |
Yield | 1.28 | 0.65 | 198% |
Fund Existence | 25 years | 4 years | - |
IJR | XJR | |
---|---|---|
RSI ODDS (%) | 3 days ago90% | 3 days ago90% |
Stochastic ODDS (%) | 3 days ago87% | 3 days ago81% |
Momentum ODDS (%) | 3 days ago81% | 3 days ago77% |
MACD ODDS (%) | 3 days ago84% | 3 days ago76% |
TrendWeek ODDS (%) | 3 days ago83% | 3 days ago79% |
TrendMonth ODDS (%) | 3 days ago84% | 3 days ago80% |
Advances ODDS (%) | 19 days ago85% | 19 days ago86% |
Declines ODDS (%) | 3 days ago85% | 3 days ago83% |
BollingerBands ODDS (%) | 3 days ago90% | 3 days ago88% |
Aroon ODDS (%) | 3 days ago83% | 3 days ago82% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BSCQ | 19.53 | 0.02 | +0.10% |
Invesco BulletShares 2026 Corp Bd ETF | |||
HYZD | 22.48 | -0.05 | -0.22% |
WisdomTree Interest Rt Hdg Hi Yld Bd ETF | |||
SMIN | 65.01 | -1.26 | -1.90% |
iShares MSCI India Small-Cap ETF | |||
AWAY | 22.20 | -0.47 | -2.07% |
Amplify Travel Tech ETF | |||
CNCR | 12.30 | -0.27 | -2.15% |
Range Cancer Therapeutics ETF |
A.I.dvisor tells us that XJR and BCC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XJR and BCC's prices will move in lockstep.